Friday, July 10, 2026

Drug profile · INN

anvumetostat

anvumetostat is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — anvumetostat
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

anvumetostat is an FDA-listed pharmaceutical active ingredient.

Key facts

INN anvumetostat

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Anvumetostat Phase 2 · Amgen · Advanced MTAP-null Solid Tumors

Frequently asked questions

What is anvumetostat?

anvumetostat is an FDA-listed pharmaceutical active ingredient.